A panel of 15 experts offered recommendations for diagnostic stewardship of urine cultures, including strategies for ordering, processing, and reporting cultures in the ED, hospital, outpatient practice, and long-term care.
7 Dec 2021
Progress made in combating HIV has caused people to feel a greater sense of security around sex and less worry about bacterial sexually transmitted infections.
1 Apr 2020
On Oct. 8, panelists will provide insight on the clinical implications of the immunology of SARS-CoV-2 and the COVID-19 vaccine, including the status of booster doses and the efficacy of vaccination in various groups.
5 Oct 2021
This issue addressed the upcoming flu season amid the COVID-19 pandemic, policies around mammography, and medical tourism.
1 Oct 2021
The consequences of postacute sequelae of COVID-19 have led to research into this emerging condition.
1 Jul 2021
IDSA releases guidance on antibiotic selection for gram-negative antimicrobial-resistant bacterial infections
New treatment guidance from the Infectious Diseases Society of America (IDSA) focused on extended-spectrum beta-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance.
15 Sep 2020
Clinician education, feedback led to fewer inappropriate antibiotics for respiratory tract infections
A stepped-wedge cluster randomized study in 31 primary care practices found that the proportion of visits with an antibiotic prescription decreased from 35.2% to 23.0% after an intervention involving clinician education and monthly peer comparison feedback.
13 Jul 2021
The battle against antimicrobial resistance requires a broad line of attack, prompting the CDC to fund projects to expand regional efforts against multidrug-resistant organisms.
1 Feb 2020
Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
1 Mar 2020
A cross-sectional survey of patients with or at risk for hepatitis C virus (HCV) found a high acceptability of long-acting treatments such as injections or implants, although daily oral medications were preferred by most. The authors noted that long-acting treatments might contribute to global efforts to eliminate HCV infection.
2 Nov 2021